I spoke with the CEO Aug 10th around 5pm EST. An 11 min

New Post Public Reply Private Reply Replies (0) Message Board
times2times2
I spoke with the CEO Aug 10th around 5pm EST. An 11 min call that started amicably but was cut short by him when I explained in detail my observations as to pps decline, note conversions, OS increase etc (all in detail providing the numbers : 160k taken [Q2 filing] for “relocation” with maturities until July 15th and 109K [Q3] with “reason not known to us” with maturity EOY and 2017; OS from 72M to 126M since we spoke last; pps from 0.008 to 0.002 since we spoke last etc) and the lack of explanation (no details about the terms of the MCV acquisition; notes taken for that during Q4???, no letter to shareholders with coming business concept etc). I did not get as far as asking about the rationale of providing the 25k loan to Hallmark Vent. while taking convertible notes themselves.

Very little information but:
1) He said all notes were and will be detailed in the financial releases every 3 months.
2) He was advised not to communicate beyond that with us (so it was me expressing concerns; not so much him responding)
3) He said the next filing is coming up in 3 weeks. I couldn’t get out of him if that would be to the acquisition terms or if he referred just to the end of the fiscal year requiring the 10k (which obviously wouldn’t be finalized right away).
4) He said, however, that the 10K will have to be filed within 71 days (not the typical 90days) due to the what he called “merger”, the acqiuisition of MCV comp. INC
5) He is truly is not following the market, the pps, the mechanistics of trading whatshowever but someone in the company does. At first he suggested I could talk to “them” another day and he took my name/number.
6) When I said how toxic it becomes when upon falling pps conversions occur (equaling e.g. 10k to 10M shares at o.oo1) and that at some point it’s a toxic spiral he said, again, someone else in the company would have to talk to me about these matters but also said “anyways we are not using this sort of financing anymore”.
7) When I asked if the management discusses matters as to share value and re-instilling investors confidence he said “Yes, a lot of things are going on” and I really would have to talk to the people dealing with this aspect of the company.


All in all a nice seemingly trustworthy guy but I understand that other board members here, just like me, cannot get specific questions across and answered. His perspectives are i) run a great business, ii) file whats required as required iii) market observation escapes him and we should talk to the others. I’m not sure if I get a call back by these guys but if not I will wait a while before I’ll try to have him get me connected. For now the only things that truly stick is 1) he listened first hand to what is going on our end, to the ever declining “market cap” via toxic financing and OTC mechanisms, and the need to full disclosure to regain investors interest and 2) that he stated “anyways we are not using this sort of financing anymore”.

Tried my best

Service Team, Inc (SVTE) Stock Research Links

SVTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Behavioral Crisis Center Saves Mobile $101M Since 2021

Updated Category News Views 0

AltaPointe Saves Millions While Supporting Community Health Let's dig into this remarkable achievement by the AltaPointe Behavioral Health Crisis Center. Since opening its doors in May 2021, the Mobile, Alabama facility has notched up a mind-boggling $101.5 million in community savings. This isn’t merely about numbers on a ledger—it's about real human impact, better...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 1

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
Replay Sports Cards Expands to Greenville With New Franchise

Updated Category News Views 0

An Old Hobby Gets New Life in Greenville Isn't it something when a hobby from your childhood eventually morphs into a business venture? That's exactly what's happening in Greenville, North Carolina, where Replay Sports Cards is laying down roots. Thanks to Jim and Jake Whitehurst's fresh franchise agreement, the card community along the eastern seaboard is about to have a...

Continue Reading
Lindian's Bold Leap into Rare Earths Processing

Updated Category News Views 0

Changing the Game in Rare Earths When Lindian Resources announces a partnership, it's not just window dressing. This time, they've linked arms with Carester SAS for a hefty venture into oxide separation. The scope? An 8,000-tonne REO facility in Kazakhstan, a place already stamped as a geological treasure chest. We're staring at what could potentially be a new dawn for...

Continue Reading
Plan A Bets on AI in High-Stakes M&A Arena

Updated Category News Views 0

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Continue Reading
BlueSky Enters Nashville: In-Home Vet Care Begins

Updated Category News Views 3

Nashville Welcomes A New Wave of Pet Care In a world where convenience is king, BlueSky At-Home Veterinary Care is stepping up to the plate—or should I say, doorstep—by rolling out its fresh take on veterinary services in Nashville. Kicking off on September 15, 2026, this isn't just any ol' run-of-the-mill clinic opening. We're talking about vets coming straight to...

Continue Reading
Nanochon Tests Innovative Knee Implant in Human Trial

Updated Category News Views 0

Mending Knees with New Tech: The Chondrograft™ Debut Picture this: Nanochon's Chondrograft™ just hit the ground running. They've got a bite out of the future by diving headfirst into their First-in-Human (FIH) clinical study. This ain't your grandma's knee replacement talk. This is about changing the game for those knee cartilages that let out a groan every time you...

Continue Reading
Herzog Joins Greenberg Traurig: A Litigation Powerhouse

Updated Category News Views 0

Greenberg Traurig Welcomes David M. Herzog to the Team Ah, the rat race of litigation just got a bit fiercer with Greenberg Traurig's latest acquisition: David M. Herzog. This isn’t just another lawyer joining the ranks; Herzog's a dynamo, coming in hot from the U.S. Attorney's Office, right onto the battlefield of corporate litigation. Why Herzog's Move Matters...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
Geron Faces Legal Woes: Investors Watch for Fallout

Updated Category News Views 1

Legal Storm Brewing Around Geron Corporation Ah, the familiar smell of trouble in corporate paradise, and this time it's drifting from Geron Corporation (NASDAQ: GERN). If you've got your chips on the table with these guys, you'd better pony up and listen up. Kuehn Law, PLLC is lighting a fire under Geron's board, snooping on whether their head honchos scuttled their...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Seek Justice in Metagenomi, Inc. Class Action Lawsuit

Updated Category News Views 45

Opportunity for Investors in Metagenomi, Inc. Securities Case Investors are presented with a significant opportunity as The Schall Law Firm steps forward to announce the initiation of a class action lawsuit against Metagenomi, Inc. (MGX). This action follows allegations of violations pertaining to federal securities laws made by the Company. Details on the Class Action...

Continue Reading
Latest Insights on Riksbank Certificate Auction Results

Updated Category News Views 229

A Closer Look at the Riksbank Certificate Auction The recent certificate auction conducted by the Riksbank has caught the attention of both investors and analysts. This event plays a vital role in managing liquidity and signaling the intentions behind monetary policy. The latest auction provided crucial figures that shed light on the current state of the economy. Overview...

Continue Reading
Understanding the Bullish Momentum Behind Meta Platforms

Updated Category News Views 104

Understanding the Bullish Momentum Behind Meta Platforms Meta Platforms (NASDAQ:META) has experienced an extraordinary surge in stock performance this year, yielding over 26% in total returns so far. This positive trajectory places it favorably among its peers in the Magnificent Seven, right behind NVIDIA’s impressive 30% climb. Such momentum can largely be attributed...

Continue Reading
Kamala Harris and Donald Trump in a Tight Race: Poll Insights

Updated Category News Views 78

Tight Race Between Candidates Revealed in Poll The latest polling data showcases an exciting contest in the presidential race. Vice President Kamala Harris holds a slight edge with 48% support from likely voters, while former President Donald Trump is close behind at 47%. This intense competition not only grabs attention but also highlights both candidates' distinctive...

Continue Reading
Rail Vision Unveils D.A.S.H. Platform, Elevating Rail Safety and Efficiency

Updated Category News Views 279

Rail Vision Launches Innovative D.A.S.H. SaaS Platform Rail Vision Ltd. (Nasdaq: RVSN), a pioneer in advancing railway safety and data-driven insights, has announced the launch of its latest Software as a Service (SaaS) platform named D.A.S.H. This platform represents a significant step forward in how rail operators can enhance safety and operational efficiency. D.A.S.H.:...

Continue Reading